End-of-day quote
Bulgaria S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.04
BGN
|
+1.34%
|
|
0.00%
|
+5.59%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
428.1
|
402.5
|
556.1
|
541.1
|
910.1
|
1,000
|
Enterprise Value (EV)
1 |
428.1
|
802.1
|
556.1
|
804.8
|
910.1
|
1,000
|
P/E ratio
|
4.93
x
|
16.1
x
|
-
|
7.43
x
|
8.41
x
|
13.1
x
|
Yield
|
-
|
1.25%
|
-
|
-
|
15.7%
|
4.97%
|
Capitalization / Revenue
|
0.33
x
|
0.28
x
|
0.35
x
|
0.33
x
|
0.49
x
|
0.5
x
|
EV / Revenue
|
0.33
x
|
0.28
x
|
0.35
x
|
0.33
x
|
0.49
x
|
0.5
x
|
EV / EBITDA
|
-
|
4.44
x
|
-
|
3.82
x
|
5.93
x
|
7.01
x
|
EV / FCF
|
-
|
-1,986,263
x
|
-
|
5,977,813
x
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
0%
|
-
|
-
|
Price to Book
|
-
|
0.73
x
|
-
|
0.77
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
125,916
|
125,769
|
124,686
|
121,319
|
159,112
|
165,622
|
Reference price
2 |
3.400
|
3.200
|
4.460
|
4.460
|
5.720
|
6.040
|
Announcement Date
|
4/29/20
|
3/1/21
|
1/31/22
|
3/1/23
|
2/29/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
1,282
|
1,440
|
1,603
|
1,663
|
1,874
|
1,989
|
EBITDA
1 |
-
|
90.61
|
-
|
141.6
|
153.4
|
142.6
|
EBIT
|
-
|
44
|
63.15
|
89.57
|
-
|
-
|
Operating Margin
|
-
|
3.06%
|
3.94%
|
5.39%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
25.39
|
-
|
87.03
|
-
|
-
|
Net income
1 |
-
|
24.98
|
91.41
|
72.55
|
95.21
|
72.19
|
Net margin
|
-
|
1.73%
|
5.7%
|
4.36%
|
5.08%
|
3.63%
|
EPS
2 |
0.6900
|
0.1990
|
-
|
0.6000
|
0.6800
|
0.4600
|
Free Cash Flow
|
-
|
-202.6
|
-
|
90.52
|
-
|
-
|
FCF margin
|
-
|
-14.07%
|
-
|
5.44%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
63.91%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
124.76%
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0400
|
-
|
-
|
0.9000
|
0.3000
|
Announcement Date
|
4/29/20
|
3/1/21
|
1/31/22
|
3/1/23
|
2/29/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
400
|
-
|
264
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
4.411
x
|
-
|
1.862
x
|
-
|
-
|
Free Cash Flow
|
-
|
-203
|
-
|
90.5
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
4.5%
|
-
|
10.7%
|
13.2%
|
8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
4.400
|
-
|
5.820
|
-
|
-
|
Cash Flow per Share
|
-
|
0.5100
|
-
|
0.8800
|
-
|
-
|
Capex
|
-
|
24.7
|
-
|
21.3
|
-
|
-
|
Capex / Sales
|
-
|
1.71%
|
-
|
1.28%
|
-
|
-
|
Announcement Date
|
4/29/20
|
3/1/21
|
1/31/22
|
3/1/23
|
2/29/24
|
-
|
Last Close Price
6.04
BGN Average target price
7.14
BGN Spread / Average Target +18.21% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.59% | 546M | | -32.21% | 15.27B | | -31.97% | 10.84B | | -30.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -0.88% | 4.71B | | +52.19% | 4.29B | | -12.31% | 3.61B | | -14.86% | 3.33B |
Other Drug Retailers
|